Shares of Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 35.92 and traded as low as GBX 30.50. Cambridge Cognition shares last traded at GBX 32, with a volume of 11,017 shares trading hands.
Cambridge Cognition Stock Performance
The firm has a market cap of £17.27 million, a PE ratio of -8.21 and a beta of 0.81. The company has a current ratio of 0.40, a quick ratio of 0.96 and a debt-to-equity ratio of 29.16. The firm has a fifty day moving average price of GBX 32.75 and a 200 day moving average price of GBX 35.86.
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
See Also
- Five stocks we like better than Cambridge Cognition
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}
